Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity
Authors
Keywords
-
Journal
Clinical Epigenetics
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-11
DOI
10.1186/s13148-021-01168-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
- (2021) Stephany Beyerstedt et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of Neuropilin-1 in COVID-19
- (2021) Bindu S. Mayi et al. PLoS Pathogens
- Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
- (2021) Kathryn E. Stephenson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro
- (2021) Sébastien Pasquereau et al. Viruses-Basel
- Histone deacetylase inhibitors suppress ACE2 and ABO simultaneously, suggesting a preventive potential against COVID-19
- (2021) Yoichiro Takahashi et al. Scientific Reports
- BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection
- (2021) Richard J. Mills et al. CELL
- Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19
- (2021) Bertram Pitt et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Yulin Zhang et al. ANNALS OF INTERNAL MEDICINE
- Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
- (2020) Pierre-Marie Duret et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach
- (2020) Yudibeth Sixto-López et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Why tocilizumab could be an effective treatment for severe COVID-19?
- (2020) Binqing Fu et al. Journal of Translational Medicine
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
- (2020) Xin Zou et al. Frontiers of Medicine
- SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
- (2020) Víctor J. Costela-Ruiz et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Coronavirus breakthrough: dexamethasone is first drug shown to save lives
- (2020) Heidi Ledford NATURE
- Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐analysis
- (2020) Michael Putman et al. Arthritis & Rheumatology
- The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
- (2020) Yu Li et al. iScience
- Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid
- (2020) Gokhan Unal et al. MEDICAL HYPOTHESES
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neuropilin-1 is a host factor for SARS-CoV-2 infection
- (2020) James L. Daly et al. SCIENCE
- Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
- (2020) Ludovico Cantuti-Castelvetri et al. SCIENCE
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- The place for remdesivir in COVID-19 treatment
- (2020) Barnaby Young et al. LANCET INFECTIOUS DISEASES
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 ( SARS‐CoV ‐2) in cultured Vero cells
- (2020) Minghui Yang et al. PHYTOTHERAPY RESEARCH
- MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti‐COVID‐19 Therapeutics
- (2020) Laura Teodori et al. Frontiers in Pharmacology
- COMPARE Analysis, a Bioinformatic Approach to Accelerate Drug Repurposing against Covid-19 and Other Emerging Epidemics
- (2020) Imad Naasani SLAS Discovery
- Valproic acid promotes a decrease in mycobacterial survival by enhancing nitric oxide production in macrophages stimulated with IFN-γ
- (2019) Erik Nieto-Patlán et al. TUBERCULOSIS
- Mechanisms and disease implications of sirtuin-mediated autophagic regulation
- (2019) In Hye Lee EXPERIMENTAL AND MOLECULAR MEDICINE
- Clinical Infections by Herpesviruses in Patients Treated with Valproic Acid: A Nested Case-Control Study in the Spanish Primary Care Database, BIFAP
- (2019) Gil et al. Journal of Clinical Medicine
- Forkhead transcription factor FOXO 3a mediates interferon‐ γ ‐induced MHC II transcription in macrophages
- (2019) Xiaoyan Wu et al. IMMUNOLOGY
- Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II Trial
- (2019) Michael Lübbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3
- (2018) Shoubo Chen et al. Journal of Neuroinflammation
- Effects of Resveratrol on the Renin-Angiotensin System in the Aging Kidney
- (2018) In-Ae Jang et al. Nutrients
- HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity
- (2016) Niek G.J. Leus et al. BIOCHEMICAL PHARMACOLOGY
- Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial
- (2016) Francesco Caponigro et al. BMC CANCER
- Valproic Acid and Lithium Meditate Anti-Inflammatory Effects by Differentially Modulating Dendritic Cell Differentiation and Function
- (2016) Sy-Jye Leu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The remarkable story of valproic acid
- (2016) Torbjörn Tomson et al. LANCET NEUROLOGY
- Inhibition of herpes virus infection in oligodendrocyte cultured cells by valproic acid
- (2016) A.J. Crespillo et al. VIRUS RESEARCH
- Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery
- (2015) Celeste B. Greer et al. Cell Reports
- Pharmacological AMP Kinase Activators Target the Nucleolar Organization and Control Cell Proliferation
- (2014) Mohamed Kodiha et al. PLoS One
- Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid
- (2013) Ángela Vázquez-Calvo et al. ANTIVIRAL RESEARCH
- Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress
- (2013) Nicola E. Clarke et al. CLINICAL SCIENCE
- Valproic Acid Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Mice
- (2013) Mu-huo Ji et al. INFLAMMATION
- Sirtuins in stress response: guardians of the genome
- (2013) L Bosch-Presegué et al. ONCOGENE
- HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade
- (2013) Y J Kim et al. ONCOGENE
- Posttranslational modifications of NF-κB: Another layer of regulation for NF-κB signaling pathway
- (2010) Bo Huang et al. CELLULAR SIGNALLING
- Inhibition of Enveloped Virus Infection of Cultured Cells by Valproic Acid
- (2010) A. Vazquez-Calvo et al. JOURNAL OF VIROLOGY
- Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation
- (2010) Danny CW Yu et al. Molecular Cancer
- Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis
- (2009) Sandra J. Saouaf et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65
- (2008) Christine Buerki et al. NUCLEIC ACIDS RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started